Vitamin D Clinical Trial
Official title:
Vitamin D Intervention in Infants - Pilot
The aims of the present study are to evaluate the concentrations of vitamin D in the plasma and of calcium in the plasma and in the urine as well as to evaluate bone mineral density using peripheral quantitative computed tomography (pQCT), after supplementation of vitamin D with 30µg (1200 IU) and 40µg (1600 IU), in comparison with currently recommended supplementation of vitamin D with 10µg (400 IU). In this pilot study supplementation is given to infants from 2 weeks of age to 3 months of age.
Vitamin D deficiency is common around the world. In Finland vitamin D levels are low in all age groups. Especially infants are predisposed to vitamin D deficiency. Partly this is due to low exposure to sunlight but mainly it is due to low dietary intake of vitamin D. Vitamin D prophylaxis was introduced in Finland in the 1950´s to overcome rickets. However, the recommended dose has decreased from 50µg (2000 IU) in the 1960´s to 10µg (400 IU) from beginning of the 1990´s. The serum concentration of 25-hydroxyvitamin D (S-25OHD) is used as a marker of vitamin D status in the body. Although there is no consensus of optimal concentration of S-25OHD, it has been proposed that concentrations lower than 50 nmol/l indicate deficiency. According to recent findings on 25-OHD concentrations in Finnish children, currently recommended intake of vitamin D is inadequate. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05186194 -
The Effect of Vitamin D and Calcium Supplementation on the Prevention of Stress Fractures.
|
N/A | |
| Recruiting |
NCT06101147 -
Effect of Vitamin D Supplementation on Testosterone Level in Women With Polycystic Ovary Syndrome
|
Phase 2 | |
| Completed |
NCT02904421 -
6 Years Study on Changes in Bone Quality, Bone Turnover and Curve Severity in AIS With and Without Calcium and Vit-D Supplementation
|
||
| Completed |
NCT02092701 -
Effects of Cholecalciferol Supplementation on Bone Health and Muscle Strength in Adults During Post-burn Period
|
N/A | |
| Completed |
NCT05748249 -
Evaluation of the Efficacy of Vertistop® D and Vertistop® L in the Prevention of BPPV Recurrence
|
Phase 1 | |
| Recruiting |
NCT04844957 -
Correlation Between Vitamin D and Symptoms Severity of Autonomic Nervous Mediated Syncope Child and it 's RAAS
|
Early Phase 1 | |
| Completed |
NCT05313477 -
The Effects of Vitamin D and Calcium Supplementation to Parathyroid Hormone in CHB Patients Treated With TDF
|
Phase 4 | |
| Not yet recruiting |
NCT01080950 -
Vitamin D Zinc Fever
|
N/A | |
| Completed |
NCT01170572 -
Longitudinal Study of Patients Following Long Bone Fracture
|
N/A | |
| Active, not recruiting |
NCT04564625 -
Relationships Between Vitamin D and Orthopedic Trauma
|
||
| Not yet recruiting |
NCT01992263 -
Vitamin D Supplementation and TB
|
N/A | |
| Completed |
NCT00938600 -
Antenatal Vitamin D3 Dose-finding and Safety Study
|
Phase 1 | |
| Completed |
NCT04535791 -
Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers
|
Phase 3 | |
| Completed |
NCT04502667 -
Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19
|
Phase 3 | |
| Recruiting |
NCT05448365 -
Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid
|
Phase 3 | |
| Recruiting |
NCT03533010 -
Preventing Curve Progression and the Need for Bracing in Adolescent Idiopathic Scoliosis With Calcium + Vitamin D Supplementation
|
N/A | |
| Recruiting |
NCT04404842 -
Development of a Screening Tool for the Risk of Vitamin D Deficiency
|
||
| Recruiting |
NCT05208827 -
Vitamin D Supplementation for the Prevention of GDM
|
Early Phase 1 | |
| Completed |
NCT05209425 -
Pharmacokinetics Evaluation of Vitamin D Formulations
|
N/A | |
| Withdrawn |
NCT03073369 -
Effect of Ergocalciferol on Iron Metabolism in Individuals With Chronic Kidney Disease
|
Phase 4 |